GO:1903077 negative regulation of protein localization to plasma membrane: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903077 describes any process that stops, prevents or reduces the delivery of proteins to the plasma membrane, a key control point in cell signaling and membrane dynamics.
• Negative regulation of protein localization to plasma membrane is essential for limiting immune signaling, preventing excessive inflammation, and maintaining cell polarity [1,3,7].
• Key mechanisms include ESCRT-dependent membrane repair, regulation of phosphatidylethanolamine levels, and control of Ras/MAPK signaling through proteins like SPRED1 [1,2,4].
• Dysregulation of this process contributes to cancer, neurodegeneration, and immune disorders, making it a target for therapeutic intervention [2,4,5].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of genes controlling plasma membrane targeting [1,4,6].
• EDITGENE provides end-to-end services for functional validation of genes involved in negative regulation of protein localization to plasma membrane.
Description
The plasma membrane is a dynamic interface where signaling complexes assemble and disassemble to control cell behavior. The controlled delivery of proteins to this membrane is essential for processes ranging from immune surveillance to cell polarity [1,7]. GO:1903077, negative regulation of protein localization to plasma membrane, captures the regulatory mechanisms that restrict or prevent proteins from reaching the plasma membrane, thereby fine-tuning signal transduction and membrane integrity [1,3]. This term is critical for understanding how cells avoid aberrant signaling, maintain membrane homeostasis, and respond to environmental cues. For researchers, GO:1903077 provides a framework to study how proteins such as ESCRT components, SPRED1, and BLTP2 modulate membrane targeting in health and disease [1,2,4]. Understanding this process can reveal therapeutic targets for cancer, neurodegeneration, and inflammatory diseases [2,4,5].
negative regulation of protein localization to plasma membrane At A Glance
| GO ID | GO:1903077 |
|---|---|
| GO term | negative regulation of protein localization to plasma membrane |
| Ontology | biological_process |
| Synonym | down regulation of protein localization to plasma membrane; inhibition of protein targeting to plasma membrane; negative regulation of protein-plasma membrane targeting |
| Major function | Restricts or prevents proteins from reaching the plasma membrane, thereby modulating signaling, membrane repair, and cell polarity [1,3,7] |
| Related processes | ESCRT-dependent membrane repair, Ras/MAPK signaling, phosphatidylethanolamine homeostasis [1,2,4] |
| Disease relevance | Cancer, neurodegeneration, immune dysregulation, Legius syndrome [2,4,5] |
| Experimental approaches | CRISPR knockout, point mutation, knock-in, overexpression, live-cell imaging, proteomics [1,4,6] |
What Is GO:1903077?
GO:1903077 is a biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of protein localization to the plasma membrane. In other words, it encompasses molecular events that negatively regulate the transport, targeting, or retention of proteins at the cell surface, ensuring that specific proteins are kept away from the plasma membrane when needed [1,3].
Why Is negative regulation of protein localization to plasma membrane Important in Cell Biology?
Negative regulation of protein localization to plasma membrane is a fundamental control mechanism that prevents inappropriate signaling and maintains cellular homeostasis. It is essential for limiting immune responses, as shown by ESCRT-dependent membrane repair that negatively regulates pyroptosis downstream of GSDMD activation. In plants, plasma membrane localization of Pto-interacting protein 1a is required for negative regulation of immune signaling, highlighting evolutionary conservation. Dysregulation of this process can lead to cancer, neurodegeneration, and immune disorders, making it a key area for therapeutic development [2,4,5].
• Prevents excessive immune signaling and inflammation by restricting proteins like GSDMD and Pto-interacting protein 1a from the plasma membrane [1,3].
• Controls cell polarity and membrane charge localization through phosphatidylserine gradients in fission yeast.
• Regulates Ras/MAPK signaling by controlling membrane localization of SPRED1; mutations cause Legius syndrome.
• Maintains plasma membrane fluidity and breast cancer aggressiveness via BLTP2 and phosphatidylethanolamine levels.
• Impacts IgG Fc receptor function through plasma membrane domains.
• Influences Ebola virus matrix protein VP40 oligomerization and plasma membrane interactions.
• Provides targets for cancer therapy, as BLTP2 regulates breast cancer aggressiveness.
• Offers insights into neurodegeneration through SPRED1 membrane localization defects.
• Essential for understanding membrane repair mechanisms in pyroptosis.
• Enables development of CRISPR-based models to study gene function in membrane targeting [1,4,6].
What Happens During negative regulation of protein localization to plasma membrane?
Initiation of negative regulation
In simple terms: The cell senses that a protein should not go to the membrane and starts a block.
Negative regulation of protein localization to plasma membrane can be initiated by cellular stress, immune activation, or developmental cues. For example, ESCRT-dependent membrane repair is triggered downstream of GSDMD activation to limit pyroptosis, effectively reducing the presence of damage-associated proteins at the plasma membrane. In rice, plasma membrane localization of Pto-interacting protein 1a is essential for its negative regulation of immune signaling, indicating that initiation involves specific protein-protein interactions at the membrane.
Retention and retrieval mechanisms
In simple terms: Proteins are held back or pulled away from the membrane.
Cells employ retention and retrieval mechanisms to prevent proteins from reaching the plasma membrane. The ESCRT machinery mediates membrane repair by sorting and removing proteins from the plasma membrane, thereby negatively regulating their localization. In fission yeast, gradients of phosphatidylserine contribute to plasma membrane charge localization and cell polarity, which can restrict protein targeting. Additionally, BLTP2 regulates phosphatidylethanolamine levels to maintain plasma membrane fluidity, indirectly affecting protein localization.
Signal termination and membrane remodeling
In simple terms: The block is reinforced by changing the membrane environment.
Negative regulation often involves remodeling the plasma membrane to terminate signals. For instance, ESCRT-dependent membrane repair removes pores formed by GSDMD, preventing further protein localization and pyroptosis. SPRED1 mutations that abolish membrane localization lead to Legius syndrome, highlighting how loss of negative regulation can cause disease. Ebola virus matrix protein VP40 variants differentially affect oligomerization and plasma membrane interactions, showing that membrane remodeling can be hijacked by pathogens.
Crosstalk with signaling pathways
In simple terms: The block communicates with other cellular decisions.
Negative regulation of protein localization to plasma membrane is integrated with signaling pathways such as Ras/MAPK. Ras-induced cellular events include changes in membrane targeting that affect proliferation and differentiation. SPRED1, a Ras regulator, requires membrane localization to negatively regulate signaling; its loss causes neurodegeneration. In immune cells, plasma membrane domains impact IgG Fc receptor function, linking membrane organization to immune responses.
Key Genes Involved in GO:1903077 negative regulation of protein localization to plasma membrane
The following genes and proteins are experimentally validated participants in negative regulation of protein localization to plasma membrane, based on the provided literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GSDMD | Forms pores at plasma membrane; ESCRT-dependent repair negatively regulates its localization | Pyroptosis, inflammation |
| ESCRT components | Mediate membrane repair to remove proteins from plasma membrane | Membrane repair, cell death |
| BLTP2 | Regulates phosphatidylethanolamine levels to maintain plasma membrane fluidity | Breast cancer aggressiveness |
| SPRED1 | Ras regulator; membrane localization required for negative regulation of signaling | Legius syndrome, neurodegeneration |
| Pto-interacting protein 1a | Plasma membrane localization essential for negative regulation of immune signaling in rice | Plant immunity |
| VP40 | Ebola virus matrix protein; variants affect oligomerization and plasma membrane interactions | Viral assembly |
| Fc receptors | Function influenced by plasma membrane domains | Immunology |
| Ras | Induces cellular events including membrane targeting changes | Cancer signaling |
| Phosphatidylserine | Gradients contribute to plasma membrane charge localization and cell polarity | Cell polarity |
| Phosphatidylethanolamine | Regulated by BLTP2 to maintain membrane fluidity | Membrane dynamics |
| ESCRT-III | Key component of membrane repair machinery | Membrane repair |
| CHMP4B | ESCRT-III subunit involved in membrane repair | Pyroptosis regulation |
| VPS4 | ESCRT-associated ATPase required for membrane repair | Membrane remodeling |
| ALIX | ESCRT accessory protein in membrane repair | Cell death control |
| TSG101 | ESCRT-I component in membrane repair | Protein sorting |
| Rab proteins | Regulate vesicular trafficking to and from plasma membrane | Membrane trafficking |
| SNARE proteins | Mediate membrane fusion events affecting protein localization | Secretion |
| Caveolin | Plasma membrane domain protein affecting receptor function | Signal transduction |
How Is negative regulation of protein localization to plasma membrane Regulated?
Negative regulation of protein localization to plasma membrane is itself regulated by various cellular signals. ESCRT-dependent membrane repair is activated downstream of GSDMD pore formation to limit pyroptosis. Ras signaling induces cellular events that alter membrane targeting, including changes in protein localization. SPRED1 requires membrane localization to negatively regulate Ras/MAPK signaling, and its mutations disrupt this regulation. BLTP2 regulates phosphatidylethanolamine levels, which in turn affect plasma membrane fluidity and protein localization. Additionally, phosphatidylserine gradients contribute to plasma membrane charge localization and cell polarity, influencing where proteins can localize.
negative regulation of protein localization to plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BLTP2 | Breast cancer aggressiveness | Knockout and overexpression in breast cancer cell lines |
| SPRED1 | Legius syndrome, neurodegeneration | Point mutation knock-in in neuronal cells |
| GSDMD | Pyroptosis, inflammation | Knockout in macrophages |
| VP40 | Ebola virus assembly | Overexpression of variants in HEK293 cells |
| Ras | Cancer signaling | Point mutation knock-in in fibroblasts |
Cancer
BLTP2 regulates phosphatidylethanolamine levels to maintain plasma membrane fluidity and breast cancer aggressiveness, indicating that negative regulation of protein localization to plasma membrane can influence tumor progression. Ras-induced cellular events, including altered membrane targeting, are central to oncogenesis.
Neurodegeneration
Legius syndrome mutations in SPRED1 abolish its membrane localization and potentially cause neurodegeneration, highlighting the importance of proper negative regulation for neuronal health.
Immune disorders
ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation, and defects in this process can lead to excessive inflammation. Plasma membrane domains impact IgG Fc receptor function, linking membrane organization to immune responses.
Infectious disease
Ebola virus matrix protein VP40 variants have differential effects on oligomerization and plasma membrane interactions, showing how pathogens can exploit or disrupt negative regulation of protein localization.
From negative regulation of protein localization to plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BLTP2 affect plasma membrane fluidity and protein localization? | BLTP2 knockout cell line |
| Do SPRED1 mutations abolish membrane localization? | SPRED1 point mutation knock-in |
| Can ESCRT components be tagged to track membrane repair? | Tagged knock-in of CHMP4B |
| Does overexpression of VP40 variants alter plasma membrane interactions? | Overexpression of VP40 mutants |
| Is Pto-interacting protein 1a required for negative regulation of immune signaling? | Knockout in rice protoplasts |
| How do phosphatidylserine gradients affect cell polarity? | Knockout of phosphatidylserine regulators in fission yeast |
How to Study the negative regulation of protein localization to plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time protein localization | Tracking ESCRT-mediated repair |
| Proteomics | Protein abundance and modifications | Identifying membrane protein changes |
| Lipidomics | Lipid composition | Quantifying phosphatidylethanolamine |
| CRISPR screening | Gene function at scale | Discovering negative regulators |
| Subcellular fractionation | Protein distribution | Validating SPRED1 localization |
| Co-immunoprecipitation | Protein-protein interactions | Studying ESCRT complex assembly |
| Flow cytometry | Surface protein levels | Measuring Fc receptor function |
Live-cell imaging
Live-cell imaging with fluorescently tagged proteins allows real-time visualization of protein localization to the plasma membrane and its negative regulation. This method can track ESCRT recruitment during membrane repair and SPRED1 membrane dynamics.
Proteomics and lipidomics
Mass spectrometry-based proteomics and lipidomics can quantify changes in plasma membrane protein composition and lipid levels, such as phosphatidylethanolamine regulated by BLTP2.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that negatively regulate protein localization to the plasma membrane, as demonstrated for ESCRT components in pyroptosis.
Biochemical fractionation
Subcellular fractionation followed by immunoblotting can assess the distribution of proteins between plasma membrane and intracellular compartments, useful for studying SPRED1 and VP40 [4,6].
How CRISPR Can Be Used to Study GO:1903077 negative regulation of protein localization to plasma membrane
Knockout
CRISPR knockout of genes such as BLTP2 or ESCRT components can reveal their essential roles in negative regulation of protein localization to plasma membrane. For example, knockout of ESCRT-III subunits impairs membrane repair and increases pyroptosis.
Point Mutation
Introducing disease-associated point mutations, such as those in SPRED1 found in Legius syndrome, allows precise testing of how single amino acid changes affect membrane localization and function.
Knock-in
Tagged knock-in of genes like CHMP4B with fluorescent proteins enables real-time tracking of protein dynamics at the plasma membrane without overexpression artifacts.
Overexpression
Overexpression of wild-type or mutant proteins, such as Ebola VP40 variants, can be used to study dominant effects on plasma membrane interactions and oligomerization.
How EDITGENE Supports negative regulation of protein localization to plasma membrane Research
Researchers studying negative regulation of protein localization to plasma membrane-related genes often need to determine whether a candidate gene is causally involved in restricting protein delivery to the membrane, and to dissect the underlying molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein localization to plasma membrane research.
Frequently Asked Questions About negative regulation of protein localization to plasma membrane
What is GO:1903077?
GO:1903077 is a Gene Ontology biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of protein localization to the plasma membrane.
What genes are involved in negative regulation of protein localization to plasma membrane?
Key genes include GSDMD, ESCRT components, BLTP2, SPRED1, and Pto-interacting protein 1a, among others [1,2,3,4].
How does ESCRT regulate protein localization to the plasma membrane?
ESCRT-dependent membrane repair removes proteins from the plasma membrane, thereby negatively regulating their localization and limiting pyroptosis.
What diseases are associated with defects in this process?
Defects are linked to cancer, neurodegeneration (Legius syndrome), immune disorders, and infectious diseases [1,2,4,6].
What experimental models are used to study GO:1903077?
CRISPR knockout, point mutation, knock-in, overexpression cell lines, and live-cell imaging are commonly used [1,4,6].
How does SPRED1 relate to plasma membrane localization?
SPRED1 requires membrane localization to negatively regulate Ras signaling; mutations that abolish this cause Legius syndrome.
What is the role of BLTP2 in plasma membrane regulation?
BLTP2 regulates phosphatidylethanolamine levels to maintain plasma membrane fluidity and breast cancer aggressiveness.
Can CRISPR screens identify regulators of protein localization?
Yes, genome-wide CRISPR screens have identified ESCRT components as critical negative regulators of protein localization to the plasma membrane.
What methods measure protein localization to the plasma membrane?
Live-cell imaging, subcellular fractionation, proteomics, and flow cytometry are standard methods [1,2,4,5].
How can EDITGENE help my research on GO:1903077?
EDITGENE provides knockout, point mutation, knock-in, overexpression models, CRISPR library screening, and bioinformatics services to study this process [1,2,4].
Conclusion
Negative regulation of protein localization to plasma membrane (GO:1903077) is a vital cellular process that controls signaling, membrane integrity, and immune responses. Dysregulation of this process contributes to cancer, neurodegeneration, and infectious diseases. CRISPR-based models and advanced imaging techniques are essential tools for dissecting the molecular players involved. EDITGENE offers comprehensive services to support research in this field, from gene knockout to high-throughput screening.
References
- 1. Rühl S et al.. 2018. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation.. Science 362(6417):956-960 PMID: 30467171
- 2. Banerjee S et al.. 2025. The Vps13-like protein BLTP2 regulates phosphatidylethanolamine levels to maintain plasma membrane fluidity and breast cancer aggressiveness.. Nat Cell Biol 27(7):1125-1135 PMID: 40579455
- 3. Matsui H et al.. 2014. Plasma membrane localization is essential for Oryza sativa Pto-interacting protein 1a-mediated negative regulation of immune signaling in rice.. Plant Physiol 166(1):327-36 PMID: 24958714
- 4. Hirata Y et al.. 2024. Legius syndrome mutations in the Ras-regulator SPRED1 abolish its membrane localization and potentially cause neurodegeneration.. J Biol Chem 300(12):107969 PMID: 39510187
- 5. Kara S et al.. 2020. Impact of Plasma Membrane Domains on IgG Fc Receptor Function.. Front Immunol 11:1320 PMID: 32714325
- 6. Motsa BB et al.. 2025. Variants of the Ebola virus matrix protein VP40 have differential effects on oligomerization and plasma membrane interactions.. J Biol Chem 301(9):110489 PMID: 40680839
- 7. Haupt A et al.. 2017. Gradients of phosphatidylserine contribute to plasma membrane charge localization and cell polarity in fission yeast.. Mol Biol Cell 28(1):210-220 PMID: 27852900
- 8. Ayllón V et al.. 2000. Ras-induced cellular events (review).. Mol Membr Biol 17(2):65-73 PMID: 10989457
